{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:55:53Z","timestamp":1773935753499,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,26]],"date-time":"2026-12-26T00:00:00Z","timestamp":1798243200000},"content-version":"am","delay-in-days":328,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K08 CA234209"],"award-info":[{"award-number":["K08 CA234209"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011104","name":"Universitat Aut\u00f2noma de Barcelona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011104","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.cbi.2025.111873","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T16:07:00Z","timestamp":1765901220000},"page":"111873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Novel MicroRNA biomarkers revealed in the serum and bile of thioacetamide induced cholangiocarcinoma"],"prefix":"10.1016","volume":"425","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7537-132X","authenticated-orcid":false,"given":"Weisheng","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7581-5744","authenticated-orcid":false,"given":"Brendon R.","family":"Herring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmine","family":"Watts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"MacVicar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Crossman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6095-7902","authenticated-orcid":false,"given":"Nilesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Shahid","family":"Mukhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavio","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8553-3652","authenticated-orcid":false,"given":"Kris V.","family":"Kowdley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0471-3978","authenticated-orcid":false,"given":"J. Bart","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cbi.2025.111873_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cgh.2012.09.009","article-title":"Classification, diagnosis, and management of cholangiocarcinoma","volume":"11","author":"Razumilava","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.cbi.2025.111873_bib2","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/j.2040-4603.2013.tb00495.x","article-title":"Physiology of cholangiocytes","volume":"3","author":"Tabibian","year":"2013","journal-title":"Compr. Physiol."},{"issue":"1","key":"10.1016\/j.cbi.2025.111873_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jhep.2023.02.027","article-title":"Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma","volume":"79","author":"Lapitz","year":"2023","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.cbi.2025.111873_bib4","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1365-2559.2011.04058.x","article-title":"Intrahepatic cholangiocarcinoma arising in chronic advanced liver disease and the cholangiocarcinomatous component of hepatocellular cholangiocarcinoma share common phenotypes and cholangiocarcinogenesis","volume":"59","author":"Xu","year":"2011","journal-title":"Histopathology"},{"issue":"2\u20133","key":"10.1016\/j.cbi.2025.111873_bib5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.mrrev.2009.07.002","article-title":"Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach","volume":"682","author":"Hern\u00e1ndez","year":"2009","journal-title":"Mutat. Res."},{"issue":"4","key":"10.1016\/j.cbi.2025.111873_bib6","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/carcin\/bgh037","article-title":"Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinoma","volume":"25","author":"Yeh","year":"2004","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.cbi.2025.111873_bib7","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1042\/bj2160701","article-title":"Effect of 1,3-diaminopropane on ornithine decarboxylase enzyme protein in thioacetamide-treated rat liver","volume":"216","author":"Seely","year":"1983","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.cbi.2025.111873_bib8","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1021\/cr300206t","article-title":"Nongenotoxic carcinogenicity of chemicals: mechanisms of action and early recognition through a new set of structural alerts","volume":"113","author":"Benigni","year":"2013","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.cbi.2025.111873_bib9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3892\/ijo.2016.3503","article-title":"Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: \u039dew trends in the development of miRNA therapeutic strategies in oncology","volume":"49","author":"Gambari","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"W1","key":"10.1016\/j.cbi.2025.111873_bib10","doi-asserted-by":"crossref","first-page":"W710","DOI":"10.1093\/nar\/gkac363","article-title":"sRNAbench and sRNAtoolbox 2022 update: accurate miRNA and sncRNA profiling for model and non-model organisms","volume":"50","author":"Aparicio-Puerta","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.cbi.2025.111873_bib11","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1002\/pmic.200400852","article-title":"A proteomic analysis of thioacetamide-induced hepatotoxicity and cirrhosis in rat livers","volume":"4","author":"Low","year":"2004","journal-title":"Proteomics"},{"key":"10.1016\/j.cbi.2025.111873_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109386","article-title":"LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4","volume":"118","author":"Yang","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.cbi.2025.111873_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14071380","article-title":"Molecular targets and signaling pathways of microRNA-122 in hepatocellular carcinoma","volume":"14","author":"Chun","year":"2022","journal-title":"Pharmaceutics"},{"issue":"23","key":"10.1016\/j.cbi.2025.111873_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13235875","article-title":"Knockdown of microRNA-214-3p promotes tumor growth and epithelial-mesenchymal transition in prostate cancer","volume":"13","author":"Cagle","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cbi.2025.111873_bib15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/s12935-020-01506-2","article-title":"MicroRNA-214-3p inhibits the stem-like properties of lung squamous cell cancer by targeting YAP1","volume":"20","author":"Lu","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"2","key":"10.1016\/j.cbi.2025.111873_bib16","first-page":"2620","article-title":"miR-214-3p promotes the proliferation, migration and invasion of osteosarcoma cells by targeting CADM1","volume":"16","author":"Cai","year":"2018","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.cbi.2025.111873_bib17","first-page":"323","article-title":"miR-223-3p targets","volume":"40","author":"Zhi","year":"2025","journal-title":"Cancer Biother. Radiopharm."},{"issue":"1","key":"10.1016\/j.cbi.2025.111873_bib18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13046-019-1079-1","article-title":"MiR-223-3p functions as a tumor suppressor in lung squamous cell carcinoma by miR-223-3p-mutant p53 regulatory feedback loop","volume":"38","author":"Luo","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.cbi.2025.111873_bib19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.18632\/aging.101763","article-title":"MiR-223-3p promotes cell proliferation and metastasis by downregulating SLC4A4 in clear cell renal cell carcinoma","volume":"11","author":"Xiao","year":"2019","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"10.1016\/j.cbi.2025.111873_bib20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3892\/etm.2022.11155","article-title":"miR-146b-5p promotes colorectal cancer progression by targeting TRAF6","volume":"23","author":"Shi","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.cbi.2025.111873_bib21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12885-016-2146-z","article-title":"MiRNA-146b-5p upregulates migration and invasion of different Papillary Thyroid Carcinoma cells","volume":"16","author":"Lima","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cbi.2025.111873_bib22","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fcell.2020.00847","article-title":"miR-146a-5p plays an oncogenic role in NSCLC via suppression of TRAF6","volume":"8","author":"Liu","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.cbi.2025.111873_bib23","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3892\/ijo.2017.4023","article-title":"MicroRNA-146a-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes","volume":"51","author":"Li","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cbi.2025.111873_bib24","article-title":"MicroRNA-34a: potent tumor suppressor, cancer stem cell inhibitor, and potential anticancer therapeutic","volume":"9","author":"Li","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"21","key":"10.1016\/j.cbi.2025.111873_bib25","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1158\/1078-0432.CCR-07-4843","article-title":"The interleukin-8 pathway in cancer","volume":"14","author":"Waugh","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.cbi.2025.111873_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18185","article-title":"IL-8 from CD248-expressing cancer-associated fibroblasts generates cisplatin resistance in non-small cell lung cancer","volume":"28","author":"Wu","year":"2024","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.cbi.2025.111873_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107692","article-title":"Interleukin-8: a chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression","volume":"219","author":"Fousek","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.cbi.2025.111873_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.yexcr.2014.02.020","article-title":"Interleukin-8 promotes canine hemangiosarcoma growth by regulating the tumor microenvironment","volume":"323","author":"Kim","year":"2014","journal-title":"Exp. Cell Res."},{"issue":"12","key":"10.1016\/j.cbi.2025.111873_bib29","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1007\/s00262-022-03223-3","article-title":"Tumor-derived IL-8 facilitates lymph node metastasis of gastric cancer via PD-1 up-regulation in CD8","volume":"71","author":"Li","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cbi.2025.111873_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.cbi.2025.111873_bib31","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.26058.1","article-title":"Interleukin-6 signalling in health and disease","volume":"9","author":"Rose-John","year":"2020","journal-title":"F1000Res"},{"issue":"1","key":"10.1016\/j.cbi.2025.111873_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1615\/CritRevImmunol.v32.i1.30","article-title":"Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease","volume":"32","author":"Iyer","year":"2012","journal-title":"Crit. Rev. Immunol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725005034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725005034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:56:02Z","timestamp":1773928562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279725005034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":32,"alternative-id":["S0009279725005034"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111873","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel MicroRNA biomarkers revealed in the serum and bile of thioacetamide induced cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111873","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111873"}}